Literature DB >> 1195467

Evaluation of biological markers in bladder cancer.

Z Wajsman, C E Merrin, T M Chu, R H Moore, G P Murphy.   

Abstract

The value of biological markers of bladder cancer was studied in 66 patients. The markers included serum and urine carcinoembryonic antigens, serum and urine fibrinogen degradation products, total lymphocyte counts, urine lymphocytes and urine cytology. A high degree of accuracy (90 per cent) was found in correlating cytology and urinary fibrinogen degradation products with the activity of the disease. Serum and urine carcinoembryonic antigens, serum fibrinogen degradation products, total lymphocyte counts and urine lymphocytes were found to have no value in screening bladder cancer patients. Urinary fibrinogen degradation products and cytology in combination are recommended for screening and followup of patients at high risk.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1195467     DOI： 10.1016/s0022-5347(17)67164-7

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


  5 in total

1.  Immunohistochemical demonstration of tumor-associated antigens with the aid of monoclonal and polyclonal antisera in carcinoma of the bladder.

Authors:  J Steffens; W Friedmann; H Lobeck
Journal:  Urol Res       Date:  1985

Review 2.  Bladder tumor markers: need, nature and application. 2. Tumor and tumor-associated antigens.

Authors:  M M Kirollos; S McDermott; R A Bradbrook
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1998

Review 3.  [Non-invasive urinary diagnosis of bladder cancer. What do we know?].

Authors:  I Kausch; A Böhle
Journal:  Urologe A       Date:  2003-04-11       Impact factor: 0.639

4.  Simultaneous determination of six tumor markers in patients with prostatic carcinoma and bladder tumors.

Authors:  B Schwemmer; W Schütz; R M Kuntz; A Lehmer
Journal:  Urol Res       Date:  1985

5.  Combination of urinary fibrinogen β-chain and tyrosine-phosphorylated proteins for the detection of bladder cancer.

Authors:  Giuliana Giribaldi; Claudia Filippini; Clara Viberti; Amina Khadjavi; Nicole Finesso; Daniela Ulliers; Stefano Turini; Bruno Emilio Bressan; Francesca Pecoraro; Mauro Prato; Alessandra Allione; Matteo De Bellis; Gabriele Montefusco; Giulia Bonomessi; Marco Allasia; Giuseppe Matullo; Francesco Soria; Paolo Gontero
Journal:  Future Sci OA       Date:  2021-10-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.